elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
Pricing
Log in
Sign up
Home
/
Subjects
/
Primary central nervous system lymphoma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Primary central nervous system lymphoma
RIS
0.001
(Research Intensity Score)
Papers
41
Top papers
Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
2024 · 13 citations
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma
2025 · 9 citations
Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma
2025 · 8 citations
High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study
2025 · 8 citations
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
2020 · 45 citations
Simultaneous Determination of Methotrexate Concentrations in Human Plasma and Cerebrospinal Fluid Using Two-Dimensional Liquid Chromatography: Applications in Primary Central Nervous System Lymphoma
2024 · 6 citations
Morphological, immunophenotypic and neuroradiological characteristics of primitive B‑large cell diffuse lymphoma of the central nervous system: A retrospective cohort analysis
2025 · 3 citations
Pathway alteration burden derived from whole‐exome sequencing is associated with survival in primary central nervous system lymphoma
2026
Vitreoretinal Lymphoma: A Comprehensive Clinical Review and Current Standards in Management
2026
Newest papers
Pathway alteration burden derived from whole‐exome sequencing is associated with survival in primary central nervous system lymphoma
2026
Vitreoretinal Lymphoma: A Comprehensive Clinical Review and Current Standards in Management
2026
Severe Central Nervous System Fungal Infection Following Tirabrutinib Administration in a Patient with Refractory Primary Central Nervous System Lymphoma: A Case Report
2026
Radiological and FDG-PET imaging features of Epstein–Barr virus–positive primary central nervous system lymphomas
2026
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma
2025 · 9 citations
Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma
2025 · 8 citations
High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study
2025 · 8 citations
Morphological, immunophenotypic and neuroradiological characteristics of primitive B‑large cell diffuse lymphoma of the central nervous system: A retrospective cohort analysis
2025 · 3 citations
Multiparametric MRI for differential diagnosis of primary central nervous system lymphoma and atypical glioblastoma: an analysis incorporating DWI, DCE-MRI, and contrast agent preload DSC-PWI
2025 · 2 citations
Browse all papers →
Primary central nervous system lymphoma's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Primary central nervous system lymphoma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link